T
Timeline
Biotech & Life Sciences · Lausanne, Switzerland · Founded 2007
Science-based longevity products targeting cellular aging MoreLess
Timeline is a Swiss consumer health biotech company, with its parent company being Amazentis, focused on developing solutions for healthy aging. The company was founded in 2007 by Chris Rinsch and Patrick Aebischer, who is a medical doctor and neuroscientist. Timeline's foundation is built on over 15 years of research that originated at the École Polytechnique Fédérale de Lausanne (EPFL). The company’s core innovation is Mitopure®, a proprietary and highly pure form of Urolithin A. This ingredient is clinically proven to target mitophagy, a key cellular process for recycling and renewing mitochondria, which are the powerhouses of cells. Optimizing mitochondrial function is essential for maintaining cellular energy, which in turn supports muscle strength, immune resilience, and skin vitality.
Timeline's business model is centered on a direct-to-consumer (DTC) approach, primarily through its e-commerce website, timelinenutrition.com, and Amazon. They offer a range of products that incorporate Mitopure®, including nutritional supplements in powder, capsule, and gummy formats, as well as a topical skincare line that includes a serum, barrier cream, and eye cream. The company's strategy involves making its clinically researched products accessible to a broad audience.
The company has secured significant strategic investments to fuel its growth, including a CHF 56M (USD 66M) Series D financing round in January 2024. This round was led by BOLD, the venture capital fund of L'Oréal, and included investment from Nestlé, which has been an investor since 2019. These partnerships are crucial for expanding into new product categories and markets across the food, beauty, and health sectors. Timeline holds over 80 patents for its innovations and has conducted more than 25 human clinical trials involving over 2000 participants.
Keywords: Urolithin A, Mitopure, cellular nutrition, longevity, healthspan, mitochondrial health, anti-aging, supplements, skincare, biotech, mitophagy, consumer health, Amazentis, cellular energy, muscle strength, immune support, direct-to-consumer, EPFL, Patrick Aebischer, Chris Rinsch
Company overview
Timeline company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2007
- Headquarters
- Lausanne, Switzerland
- Employees
- 95
- Open positions
- None listed
- Dealroom signal
- 91.3
Valuation & funding
Timeline funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | May 2025 | $250K | — | X PRIZE Foundation | ↗ |
| SERIES DOther financing | Jan 2024 | $66M | $264M | Nestlé · L'Oreal | ↗ |
| EARLY VCOther financing | Apr 2019 | — | — | Undisclosed | — |
| SERIES COther financing | Mar 2018 | $8.9M | $36M | Undisclosed | ↗ |
| FundingOther financing | Aug 2015 | $0 | — | Gurnet Point Capital | — |
| SPINOUTOther financing | Dec 2007 | EPFL Swiss Federal Polytechnic School of Lausanne | — | ||
| SPINOUTOther financing | Dec 2007 | EPFL Swiss Federal Polytechnic School of Lausanne | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $488K | 0% | 95 |
| 2025 | $488K | 0% | 84 |
| 2024 | $488K | 0% | 52 |
| 2023 | $488K | 0% | 36 |
| 2022 | $488K | 0% | 31 |
| 2021 | $488K | 0% | 20 |
| 2020 | $488K | — | 14 |
Growth signals
Timeline website traffic
Latest recorded traffic for Timeline is 170K monthly website visits, down 19% over the last three months. Timeline's team grew 13.1% over the past year.
Comparisons
Timeline compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Timeline's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on Timeline's cap table
Sourced from Dealroom's funding and investor records.





Global footprint
Where Timeline has talent and traffic
team presence
In the news
Latest news about Timeline
Recent press, funding announcements, and product moves mentioning Timeline — open to read from the original sources.
Market sentiment
What the market is saying about Timeline
An AI-synthesized read of the highest-engagement posts about Timeline on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Timeline’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







